Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.1K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.1K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.0K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.0K
Stimulants01:29

Stimulants

973
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
973
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

1.0K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.0K
Motor Unit Stimulation01:20

Motor Unit Stimulation

3.8K
When the neuron of a motor unit fires an action potential, it triggers a series of events, leading to a twitch contraction in the muscle fibers. The process of excitation-contraction coupling is crucial in relaying the action potential to the muscle fibers.
The latent period of contraction marks the onset of excitation-contraction coupling, when the action potential propagates across the sarcolemma, preparing the muscle fibers for contraction. As the fibers enter the contraction phase, the...
3.8K
Muscle Stimulation Frequency01:22

Muscle Stimulation Frequency

4.5K
The contraction strength of muscles is regulated by motor neurons, which modulate the frequency of action potentials dispatched to the motor units based on the body's requirements. This process of varying the muscle stimulation frequency allows muscles to contract with a force that is precisely tailored to the needs of the moment, whether lifting a feather or a heavy box.
Wave summation
At low firing rates, motor neurons induce individual twitch contractions in muscle fibers. These twitches...
4.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Underscore of geographical and referral barriers to deep brain stimulation treatment: A look at Parkinson's and essential tremor patients in Western New York.

Clinical neurology and neurosurgery·2026
Same author

Identifying Optimal Drug Loading in Stable Amorphous Solid Dispersion Formulations: A Rheological Approach.

AAPS PharmSciTech·2026
Same author

Predicting prosthesis use and mobility needs in lower limb amputees: a machine learning approach using clinical and actigraphy data.

Journal of neuroengineering and rehabilitation·2026
Same author

References values and standardized testing protocols for performance-based and patient-reported outcome measures among individuals with lower limb amputation.

Frontiers in rehabilitation sciences·2026
Same author

Massive Honeybee Envenomation: A Case Series of Simultaneous Multiple Casualties.

The Israel Medical Association journal : IMAJ·2026
Same author

Impact of Spinal Canal Anatomy on Pain Outcomes in Spinal Cord Stimulation Therapy for Chronic Pain.

World neurosurgery·2025

Related Experiment Video

Updated: Jan 27, 2026

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

23.1K

Deep Brain Stimulation for Parkinson Disease.

Michael Kogan1, Matthew McGuire2, Jonathan Riley3

  • 1Department of Neurosurgery, University at Buffalo, 100 High Street Section B, 4th Floor, Buffalo, NY 14203, USA.

Neurosurgery Clinics of North America
|March 23, 2019
PubMed
Summary

Parkinson disease (PD) is a common neurodegenerative disorder affecting over 1 million Americans. Deep brain stimulation (DBS) offers a treatment for PD, with ongoing technological advancements continually improving its application.

Keywords:
Deep brain stimulationLevodopaParkinson disease

More Related Videos

Using Saccadometry with Deep Brain Stimulation to Study Normal and Pathological Brain Function
05:44

Using Saccadometry with Deep Brain Stimulation to Study Normal and Pathological Brain Function

Published on: July 14, 2016

7.9K
Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

2.2K

Related Experiment Videos

Last Updated: Jan 27, 2026

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

23.1K
Using Saccadometry with Deep Brain Stimulation to Study Normal and Pathological Brain Function
05:44

Using Saccadometry with Deep Brain Stimulation to Study Normal and Pathological Brain Function

Published on: July 14, 2016

7.9K
Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

2.2K

Area of Science:

  • Neurology
  • Biomedical Engineering

Background:

  • Parkinson disease (PD) is a prevalent neurodegenerative condition impacting over 1 million people in the U.S.
  • Deep brain stimulation (DBS) is an established therapeutic intervention for PD management.

Purpose of the Study:

  • To review the current landscape of Deep Brain Stimulation (DBS) for Parkinson disease (PD).
  • To highlight the impact of technological innovations on DBS therapy for PD.

Main Methods:

  • Literature review of recent advancements in DBS technology for Parkinson disease.
  • Analysis of how technological innovations are shaping DBS treatment protocols.

Main Results:

  • DBS is a key treatment modality for Parkinson disease.
  • Technological innovations are continuously refining DBS efficacy and application.

Conclusions:

  • Deep brain stimulation (DBS) remains a critical treatment for Parkinson disease (PD).
  • The evolution of DBS technology is crucial for advancing PD therapy and patient outcomes.